Evidence map›Paper›PMID 35520676›Full record

ArticleRSC advances2020

Structure-activity relationship and mechanism of four monostilbenes with respect to ferroptosis inhibition.

Xiaojian Ouyang, Xican Li, Jie Liu, Yangping Liu, Yulu Xie, Zhongcun Du, Hong Xie, Ban Chen, Wenbiao Lu, Dongfeng Chen

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Xiaojian OuyangSchool of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine Guangzhou 510006 China lixican@126.com.
Xican LiSchool of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine Guangzhou 510006 China lixican@126.com.ORCID https://orcid.org/0000-0002-4358-3993
Jie LiuSchool of Basic Medical Science, Guangzhou University of Chinese Medicine Guangzhou 510006 China chen888@gzucm.edu.cn.
Yangping LiuSchool of Basic Medical Science, Guangzhou University of Chinese Medicine Guangzhou 510006 China chen888@gzucm.edu.cn.
Yulu XieSchool of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine Guangzhou 510006 China lixican@126.com.
Zhongcun DuSchool of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine Guangzhou 510006 China lixican@126.com.
Hong XieSchool of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine Guangzhou 510006 China lixican@126.com.
Ban ChenSchool of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine Guangzhou 510006 China lixican@126.com.
Wenbiao LuSchool of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine Guangzhou 510006 China lixican@126.com.
Dongfeng ChenSchool of Basic Medical Science, Guangzhou University of Chinese Medicine Guangzhou 510006 China chen888@gzucm.edu.cn.
Guangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erastin-treated bone marrow-derived mesenchymal stem cells (bmMSCs) were prepared and used to compare the ferroptosis inhibitory bioactivities of four monostilbenes, including rhapontigenin (1a), isorhapontigenin (1b), piceatannol-3'-

Identifiers

PMID35520676
PMCPMC9056428
OpenAlexW3081380992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.